Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Return on Assets (2018 - 2025)

Historic Return on Assets for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to 0.71%.

  • X4 Pharmaceuticals' Return on Assets fell 6200.0% to 0.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71%, marking a year-over-year decrease of 6200.0%. This contributed to the annual value of 0.26% for FY2024, which is 4100.0% up from last year.
  • X4 Pharmaceuticals' Return on Assets amounted to 0.71% in Q3 2025, which was down 6200.0% from 0.87% recorded in Q2 2025.
  • In the past 5 years, X4 Pharmaceuticals' Return on Assets ranged from a high of 0.11% in Q2 2024 and a low of 1.04% during Q2 2022
  • Moreover, its 5-year median value for Return on Assets was 0.69% (2023), whereas its average is 0.6%.
  • Over the last 5 years, X4 Pharmaceuticals' Return on Assets had its largest YoY gain of 11000bps in 2025, and its largest YoY loss of -9800bps in 2025.
  • Quarter analysis of 5 years shows X4 Pharmaceuticals' Return on Assets stood at 0.75% in 2021, then rose by 6bps to 0.7% in 2022, then increased by 10bps to 0.63% in 2023, then skyrocketed by 63bps to 0.23% in 2024, then plummeted by -207bps to 0.71% in 2025.
  • Its last three reported values are 0.71% in Q3 2025, 0.87% for Q2 2025, and 0.11% during Q1 2025.